We recently observed that 13% of 1,008 consecutive adults aged 15-49 years with first-ever ischemic stroke had one or more silent brain infarcts (SBIs), and more than 5% presented with leukoaraiosis on CT or MRI. We sought to investigate the features of and risk factors for magnetic resonance (MR)-defined SBIs and leukoaraiosis in these patients.
Silent brain infarcts (SBIs)-ischemic lesions lacking corresponding overt stroke-like symptoms-are frequently seen in apparently healthy elderly populations. 1 Up to half of patients with cardiovascular risk factors are harboring SBIs on MRI, 1 and in a series of older patients with first-ever ischemic stroke, this percentage was as high as 57%. 2 Age and hypertension are the most widely recognized risk factors for SBIs, and association with small-vessel disease is explicit in the elderly. 1 In addition to SBIs, leukoaraiosis-defined as bilateral patchy or diffuse areas of low attenuation on CT or hyperintense T2 magnetic resonance (MR) areas-also is a common finding among older populations [3] [4] [5] and in stroke patients. 6 Leukoaraiosis shares similar risk factors and pathophysiologic mechanisms with both ischemic and hemorrhagic stroke, and as with SBIs, it is associated mainly with small-vessel pathology. 7 In general populations, both SBIs and leukoaraiosis are associated with a high risk of recurrent stroke events and cognitive decline. 8, 9 After an acute ischemic stroke, SBIs may not have impact on prognosis, 10 but leukoaraiosis is associated with increased risk of death or dependency, recurrent stroke, intracerebral hemorrhage under anticoagulation, myocardial infarction, and poststroke dementia. 6 Regarding younger adults, data on SBIs and leukoaraiosis are limited. 4, 11, 12 We have recently observed that approximately 13% of 1,008 consecutive young adults aged 15-49 years with first-ever ischemic stroke had one or more SBIs and more than 5% presented with leukoaraiosis on CT or MRI. 13 Young adults have a different risk factor profile and stroke etiology compared with the elderly. Small-vessel disease and large-artery atherosclerosis are much less frequent, whereas cervical artery dissection and cardioembolism are common. However, the spectrum of underlying stroke mechanisms is extremely wide. Therefore, we hypothesized that risk factors, imaging characteristics, and associations with the overt clinical stroke may be different in young patients with ischemic stroke and with, or without, SBIs and leukoaraiosis.
METHODS This study was approved by the relevant authorities and performed at the Department of Neurology, Helsinki University Central Hospital. We included patients involved in the Helsinki Young Stroke Registry, 13 from 1994 to 2007, who had undergone an initial brain MR scan at 1.0 or 1.5 teslas. The patients were originally found by computer search of the hospital's electronic database according to the following criteria: discharge diagnosis of an ischemic stroke, age 15-49 years at stroke onset, and patient living in the catchment area of the hospital. Only patients with first-ever ischemic stroke were included in the registry. In addition to those with false primary diagnosis, we excluded patients with TIA, cerebral venous thrombosis, stroke due to direct head trauma or strangulation, ischemic lesion due to immediate complications originating from subarachnoidal hemorrhage, and any iatrogenic stroke as a consequence of angiographic imaging or major surgery. Of the 1,194 consecutive patients found by the computer search, 1,008 were included in the registry, and of these, 671 patients were initially scanned with MRI. Of the MR-scanned patients, 669 had complete imaging data, being eligible for the present study. They represented well the entire cohort of 1,008 patients (figure e-1 on the Neurology ® Web site at www.neurology.org).
We obtained demographic and risk factor data from the medical records. The definitions of risk factors were based on information available before the onset of the stroke, and on all poststroke diagnostic testing related to the current stroke. All patients underwent routinely a range of laboratory testing, which are described in detail elsewhere. 13 Family history of any stroke was defined as history of ischemic or hemorrhagic stroke, or TIA, in a first-degree relative. Dyslipidemia was defined as treated with lipid-lowering medication or total cholesterol level Ն5.0 mmol/L (193 mg/dL), low-density lipoprotein level Ն3.0 mmol/L (116 mg/dL), or high-density lipoprotein level Ͻ1.0 mmol/L (39 mg/dL). Hypertension was defined as treated with antihypertensives, or a history or present diagnosis of hyperten-sion according to the 2003 World Health Organization criteria as systolic blood pressure Ն140 mm Hg and/or diastolic blood pressure Ն90 mm Hg. A patient was considered as current smoker if smoking regularly Ն1 cigarettes per day within the year before stroke. We defined obesity as body mass index (BMI) Ն30 kg/m 2 or patient clearly stated as heavily obese if BMI data were not available. Cardiovascular disease was defined as any of coronary heart disease, heart failure, myocardial infarction, or peripheral arterial disease. Diabetes mellitus type 1 and 2 were separately registered and defined as treated or presently diagnosed according to the 1999 World Health Organization criteria as fasting plasma glucose Ն7.0 mmol/L (126 mg/dL). In Finland, children and young adults with newly diagnosed type 1 diabetes are almost invariably diagnosed and treated in hospital, and the diagnosis is based on clinical characteristics, C-peptide measurements, and where necessary, glutamate decarboxylase antibody measurements. The type of diabetes is thus reliably distinguished based on information obtained from the medical records. Other registered risk factors were chronic or paroxysmal atrial fibrillation, and migraine, the latter defined according to the International Headache Society criteria. 14 We classified stroke subtypes according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. 15 A pair of investigators assigned the stroke subtype to each patient, and in case of discrepancy, the patient records were reviewed by a senior investigator and the final categorization was based on a consensus agreement of all three.
All brain imaging studies were originally interpreted by neuroradiologists. Analysis and rating of SBIs and leukoaraiosis were performed by study stroke neurologists and senior neuroradiologist (O.S.) blinded to clinical data. We defined SBI as focal hyperintensity on T2-weighted images, 3 mm in size or larger, and without a history of corresponding neurologic symptoms or signs. To distinguish infarcts from leukoaraiosis, infarcts had to have corresponding hypointensity on T1-weighted images. We measured the diameter of each SBI in millimeters using axial images and registered brain side, as well as calculated the number of SBIs for each patient. Localization of each SBI was classified as follows: cortical, cerebellum, brainstem (including pons), thalamus, lacune subcortical, and lacune basal ganglia.
Leukoaraiosis was defined as hyperintense lesions in periventricular or subcortical regions, or in pons, on fluid-attenuated inversion recovery MRI sequences, and, in two patients, on T2weighted sequences. We evaluated leukoaraiosis according to a previously validated visual rating scale developed in our hospital. 16, 17 The reliability of rating have been tested and found to be good (intraobserver agreement, weighted ϭ 0.90 -0.95; interobserver agreement, weighted ϭ 0.72-0.84). 16, 17 Periventricular hyperintensities (PVHs) around frontal and occipital horns, along the bodies of lateral ventricles, and in regions other than periventricular white matter were classified and scored based on shape and size of the lesions (table 1) . Presence of pontine leukoaraiosis was additionally scored. Scores of these four components were added up for each patient, and the sum score was categorized into mild (1-4), moderate (5) (6) (7) (8) , or severe (9 -12) . Presence of leukoaraiosis was thus defined as any score greater than zero.
Chi-square and Fisher exact tests allowed comparisons of categorical variables between the groups. The Student t test was used for comparisons of means, and the Mann-Whitney U test was used for ordinal variables. Backward stepwise multivariate logistic regression models were used to identify independent risk factors predisposing to presence of SBIs, leukoaraiosis, and concurrence of both. In addition to age and sex, we included vari-ables with a univariate p Ͻ 0.10 in each of the three multivariate models. Historic risk factor information based on self-reporting (migraine, smoking, and family history of stroke) that was not mentioned in the medical records was considered as being not present. Otherwise, there were no missing values in risk factor variables. All statistical analyses used SPSS 15.0 for Microsoft Windows (SPSS Inc., Chicago, IL). Two-sided values of p Ͻ 0.05 were considered significant.
RESULTS
Of the 669 patients included, 86 (13%) had one or more SBIs and 50 (7%) had leukoaraiosis. Among these, 17 (3%) had both findings. In total, 550 (82%) patients were free of SBIs and leukoaraiosis, serving as a control group. In the study population, SBIs began to appear at age 26 years and leukoaraiosis began to appear at age 35 years, whereas the proportion of patients free of SBIs and leukoaraiosis strikingly decreased with aging ( figure 1 ).
We identified a total of 276 SBIs in our patients. The majority (n ϭ 46, 54%) had only a single lesion, 17 (20%) had two lesions, and 23 (27%) patients had three or more lesions. SBIs were located mostly in basal ganglia and subcortical regions, but silent lesions in cerebellum were rather frequent as well (figure 2). The majority of patients had right-sided SBIs (n ϭ 37, 43%), whereas 22 patients (26%) had left-sided lesions, and 27 patients (31%) had bilateral SBIs. The average SBI diameter was 9 mm, ranging from 3 to 83 mm, the latter in a 46-year-old man with an SBI in the right frontotemporal cortex.
Most patients with leukoaraiosis had mild to moderate changes (table 1) . Males had a slightly higher leukoaraiosis score (mean score 5.4 Ϯ 2.0 vs 4.7 Ϯ 2.2, p ϭ 0.217). SBIs were located mainly in basal ganglia in those 17 with concurrent leukoaraiosis and SBIs. PVHs around frontal and occipital horns most often appeared in the forms of a small or large cap. PVHs along the bodies of lateral ventricles were mostly characterized by thin lining. Hyperintensities in regions other than periventricular white matter varied the most from small focal lesions to extensive white matter change, the latter in a patient with a long history of untreated grave hypertension and acute presentation of hypertensive encephalopathy and ischemic stroke.
Stroke risk factors and etiology of the first-ever overt stroke in the study population are shown in table 2. As expected, patients with SBI, leukoaraiosis, or both were older compared with controls free of these findings. Hypertension, both types of diabetes, cardiovascular disease, obesity, smoking, and dyslipidemia were more frequent in patients with SBIs compared with controls. In patients with leukoaraiosis, hypertension, obesity, type 1 diabetes mellitus, and cardiovascular disease were more common.
SBIs and leukoaraiosis clearly were more often present in patients with first-ever overt infarct associ- ated with small-vessel disease or large-artery atherosclerosis, and less common in those with other determined or undetermined etiology. In patients with SBIs, the specific causes of stroke in the other determined category (TOAST 4) were as follows: primary angiitis of the CNS (PACNS) (n ϭ 5), cervical artery dissection (4), hypertensive encephalopathy (2), factor V Leiden mutation (2), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (1), systemic lupus erythematosus (SLE) (1), and radiation vasculopathy (1). Accordingly, leukoaraiosis was found in those with PACNS (n ϭ 2), CADASIL (2), hypertensive encephalopathy (1), SLE (1), and radiation vasculopathy (1). In the multivariate models, increasing age, obesity, and type 1 diabetes were independently associated with the risk of both SBIs and leukoaraiosis adjusted for age, sex, and other relevant risk factors (table 3) . The associations were clearly strongest with type 1 diabetes. Smoking was associated with SBIs but not with leukoaraiosis. Females tended to have an increased risk for leukoaraiosis; otherwise, we observed no clear sex preference. Hypertension had only a trend-like association with both SBIs and leukoaraiosis alone. In addition to increasing age, smoking, hypertension, and in particular type 1 diabetes were independent predisposing factors in those with concurrent SBIs and leukoaraiosis. DISCUSSION SBIs and leukoaraiosis were common findings among our young stroke patients. SBIs were seen already in early adulthood, whereas leukoaraiosis began to appear at early midlife. Apart from increasing age, juvenile-onset diabetes mellitus was the strongest risk factor for both SBIs and leukoaraiosis in this young patient population.
In our young patients, the prevalence of SBIs and leukoaraiosis increased with aging and occurred in parallel with the exponentially increasing occurrence rate of first-ever overt ischemic stroke. 13 More than one-fourth among patients aged 45-49 years and nearly one-fifth among patients aged 40 -44 years had SBIs, leukoaraiosis, or both (figure 1). In previous community-based and population-based studies involving mostly elderly persons, the reported prevalences of SBIs on MRI have ranged from 8% to 28% and have depended mainly on age. 1 Two studies have documented the prevalence of SBIs in detail in healthy middle-aged subjects: the prevalence among younger participants was 0% in those aged 20 -39 years and 1.7% in those aged 40 -49 years in a South Korean study, 12 and Ͻ8% among those aged 30 -49 years in the Framingham Offspring Study. 11 The prevalence of MR-defined SBIs in older Japanese patients (mean age 69 years) with first-ever ischemic stroke was 57%. 2 This high percentage may well correlate with our observations of the steeply increasing frequency of SBIs with aging. However, Japanese are known to have a high frequency of small-vessel disease, which associates strongly with SBIs.
Akin to previous studies, which have enrolled mostly elderly persons, 11, 12, [18] [19] [20] [21] [22] most SBIs in our patients were located in subcortical deep white matter and basal ganglia, which thus reflect the probable underlying small-vessel pathology. However, we observed a considerably higher proportion of silent cerebellar infarcts (15%) in our young patients compared with that registered in the healthy elderly (1%-8%) 11, 12, 19, 20, 22 or in patients with acute ischemic stroke scanned with CT (7%). 23 Migraine was suggested as an independent risk factor particularly for cerebellar silent ischemic lesions in the general population. 24 In contrast, we did not find such association in our young stroke patients. Compared with our series, participants in that study 24 were older, and Proportions of patients with MRI-defined silent brain infarcts or leukoaraiosis as a function of age in the patient cohort (n ‫؍‬ 669)
Regarding corresponding dark-green bars: *1%, **2%. SBI ϭ silent brain infarct.
Figure 2 Proportions of locations of MRI-defined silent brain infarcts, average size of lesions, and range of sizes in each location
only four were younger than 50 years, which probably reflects that increasing age is the major predisposing factor for SBIs in migraineurs as well. Silent cardioembolism may in part explain the frequency of cerebellar SBIs in our patients, because those with identified cardioembolic source underlying the overt stroke were rather numerous. As observed, younger stroke patients tend to have more frequently overt posterior territory ischemia and cerebellar infarcts. 13 This observation, jointly with the frequency of cerebellar SBIs, might reflect the same-yet unclearpathophysiologic mechanisms. The observed side preference of SBIs likely reflects the fact that symptoms arising from lesions in the nondominant hemisphere are not well recognized even in the young. 13 Leukoaraiosis is increasingly apparent after age 50 years, and the prevalence is very high in elderly populations. [3] [4] [5] 25 In mostly older patients with TIA or stroke, leukoaraiosis was present in 44%. 6 A community-based Japanese study revealed a prevalence of a few percent in participants in their 40s. 4 In our study, the prevalence was 6% both in patients aged 35-39 years and in those aged 40 -44 years but doubled in the age group of 45-49 years, which reflects that age is also the major determinant for leukoaraiosis. 26 We used a leukoaraiosis rating scale that takes into account the number, size, and shape of Table 3 Multivariate logistic regression models analyzing independent predictors of the presence of magnetic resonance-defined SBIs, LA, and concurrence of both The listed values represent variables included, and those free of silent brain infarcts (SBIs) and leukoaraiosis (LA) (n ϭ 550) served as a control group in each model. Data are expressed as odds ratio (OR) and 95% confidence interval (CI). leukoaraiotic lesions. 27 According to our simple scoring system-considering all white matter areas and brainstem-our young patients had mostly mild to moderate leukoaraiotic changes, whereas males had slightly more severe lesions. The latter is opposite to the trend observed in the general population. 3 However, our relatively small number of patients with leukoaraiosis may not allow firm conclusions on this issue. Silent myocardial infarctions are frequently seen among patients with type 1 diabetes, 28 but to our knowledge, the strong associations between type 1 diabetes and early-onset SBIs or leukoaraiosis have not been previously observed. Results on the association of type 2 diabetes with both SBIs and leukoaraiosis in elderly populations have been conflicting. 1, 4, 11, 20, 26, 29 This may be due to weak associations, small sample sizes, or a combination of both. Interestingly, the well-established associations between hypertension and SBIs 1 and leukoaraiosis 29 were not that clear in our series, and were only seen in those with coexistent SBIs and leukoaraiosis, who also were older. Likely explanations for these observations are that in younger patients, hypertension may not have had enough time to cause advanced vessel pathology, whereas juvenile-onset diabetes and chronic hyperglycemia may have altered the endothelial function, leading to early atherosclerosis, possibly for years or decades before stroke. 30 Recently, there has been a growing attention on the association between metabolic syndrome, its components, and SBIs 31 as well as leukoaraiosis. 32 This association is also obvious in our series, because obesity was related with the presence of both SBIs and leukoaraiosis. Smoking was associated with SBIs only in two prior studies, 1 but its relation to pathogenesis of leukoaraiosis or small-vessel disease is even more controversial. 26, 33 Accordingly, in our young patients, smoking was associated with SBIs but not with leukoaraiosis. However, as with hypertension, smoking was clearly associated with coexistent SBIs and leukoaraiosis.
Small-vessel disease is the most likely stroke subtype associated with the presence of both SBIs 1 and leukoaraiosis. 6 However, the etiology of overt stroke does not necessarily correlate with the pathophysiology of underlying SBIs and leukoaraiosis. Given the overall high frequency of vascular risk factors in our patients, 13 those with non-small-vessel disease related stroke also may harbor risk factors predisposing to small-vessel pathology. This is obvious particularly in those with large-artery atherosclerosis. In addition, SBIs may well be related to conditions such as cervical artery dissection or PACNS per se, considering their pathophysiologic mechanisms and often slowly or gradually evolving pathogenesis. 34, 35 Both SBIs and leukoaraiosis are characteristic even in younger patients with CADASIL. 36 Our study has several limitations. It covers a long time period and is subject to variability in MR technology. We may have misclassified a few SBIs because of incomplete patient history information or because some patients may not recall their stroke symptoms or correctly interpret all their previous symptoms. The Helsinki Young Stroke Registry includes only patients younger than 50 years and with first-ever ischemic stroke, reducing this possibility. Approximately one-third of our patients in the registry were scanned only with CT and were excluded from the present study, which may have led to slight underestimation of small SBIs in the entire cohort of 1,008 consecutive patients. However, including only MR-scanned patients was reasonable because sensitivity to detect and classify infarcts on MRI is clearly better than on CT. 1 Because of the study design, we may have underestimated the prevalence of some historic risk factors, such as smoking or family history of stroke. Numbers of patients particularly in the leukoaraiosis and combined SBI and leukoaraiosis groups were relatively small, which should be taken into account when interpreting the results of the multivariate analyses. Finally, because we included only stroke patients, the issue of whether the observed risk factor associations also are present in young people without any history of an overt stroke should be tested in large-scale studies.
